T. Arbizu

1.2k total citations
28 papers, 745 citations indexed

About

T. Arbizu is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, T. Arbizu has authored 28 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pathology and Forensic Medicine, 14 papers in Neurology and 7 papers in Oncology. Recurrent topics in T. Arbizu's work include Multiple Sclerosis Research Studies (22 papers), Peripheral Neuropathies and Disorders (10 papers) and Polyomavirus and related diseases (4 papers). T. Arbizu is often cited by papers focused on Multiple Sclerosis Research Studies (22 papers), Peripheral Neuropathies and Disorders (10 papers) and Polyomavirus and related diseases (4 papers). T. Arbizu collaborates with scholars based in Spain, Poland and Hungary. T. Arbizu's co-authors include Albert Saiz, Francesc Graus, Óscar Fernández, Basil Sharrack, Sámuel Komoly, Massimo Filippi, Eva Havrdová, Marco Rovaris, Oded Abramsky and Krzysztof Selmaj and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

T. Arbizu

28 papers receiving 718 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Arbizu Spain 15 563 216 165 161 154 28 745
Alexandra Degenhardt United Kingdom 9 655 1.2× 243 1.1× 218 1.3× 137 0.9× 101 0.7× 10 769
А. Н. Бойко Russia 12 707 1.3× 248 1.1× 228 1.4× 169 1.0× 247 1.6× 75 995
Alexander Musallam United States 15 710 1.3× 245 1.1× 186 1.1× 117 0.7× 179 1.2× 21 1.0k
M. Cossburn United Kingdom 10 495 0.9× 241 1.1× 150 0.9× 120 0.7× 174 1.1× 17 687
M. S. Freedman Canada 9 411 0.7× 177 0.8× 132 0.8× 108 0.7× 105 0.7× 16 536
Pietro Iaffaldano Italy 18 705 1.3× 197 0.9× 139 0.8× 195 1.2× 92 0.6× 56 898
Peter Huppke Germany 20 756 1.3× 491 2.3× 218 1.3× 160 1.0× 127 0.8× 39 1.1k
Marc Coustans France 10 689 1.2× 338 1.6× 197 1.2× 249 1.5× 98 0.6× 10 878
Anton Vladić Croatia 12 452 0.8× 218 1.0× 141 0.9× 190 1.2× 199 1.3× 26 726
J. Deans United Kingdom 8 621 1.1× 307 1.4× 212 1.3× 139 0.9× 275 1.8× 10 1.0k

Countries citing papers authored by T. Arbizu

Since Specialization
Citations

This map shows the geographic impact of T. Arbizu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Arbizu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Arbizu more than expected).

Fields of papers citing papers by T. Arbizu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Arbizu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Arbizu. The network helps show where T. Arbizu may publish in the future.

Co-authorship network of co-authors of T. Arbizu

This figure shows the co-authorship network connecting the top 25 collaborators of T. Arbizu. A scholar is included among the top collaborators of T. Arbizu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Arbizu. T. Arbizu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garcı́a-Merino, A., Óscar Fernández, Xavier Montalbán, et al.. (2013). Documento del Grupo de Consenso de la Sociedad Española de Neurología sobre el uso de medicamentos en esclerosis múltiple. Neurología. 28(6). 375–378. 10 indexed citations
2.
Garcı́a-Merino, A., Óscar Fernández, Xavier Montalbán, et al.. (2013). Consensus statement on medication use in multiple sclerosis by the Spanish Society of Neurology's study group for demyelinating diseases. SHILAP Revista de lepidopterología. 28(6). 375–378. 9 indexed citations
3.
Fernández, Óscar, J.A. García-Merino, Rosa Arroyo-García, et al.. (2012). Spanish consensus on the use of natalizumab (Tysabri®) – 2011. SHILAP Revista de lepidopterología. 27(7). 432–441. 7 indexed citations
4.
Fernández, Óscar, J.A. García-Merino, Rosa Arroyo-García, et al.. (2011). Consenso español sobre la utilización de natalizumab (Tysabri®) - 2011. Neurología. 27(7). 432–441. 8 indexed citations
5.
Martínez‐Yélamos, Sergio, Laura Bau, Elisabet Matas, et al.. (2011). Association of HLA‐DRB1*15 allele and CSF oligoclonal bands in a Spanish multiple sclerosis cohort. European Journal of Neurology. 18(10). 1258–1262. 17 indexed citations
6.
7.
Fernández, Óscar, Victoria Fernández, T. Arbizu, et al.. (2010). Characteristics of multiple sclerosis at onset and delay of diagnosis and treatment in Spain (The Novo Study). Journal of Neurology. 257(9). 1500–1507. 50 indexed citations
8.
Fernández, Óscar, et al.. (2010). Spanish Neurology Society consensus document on the use of drugs in multiple sclerosis: Escalating therapy. SHILAP Revista de lepidopterología. 25(6). 378–390. 11 indexed citations
9.
Alonso-Magdalena, Lucía, Lucía Romero, Esther Moral, et al.. (2010). Anticipation of age at onset in multiple sclerosis: methodologic pitfalls. Acta Neurologica Scandinavica. 121(6). 426–428. 5 indexed citations
10.
Pujal, Josep M., Sergio Martínez‐Yélamos, Elisabet Matas, et al.. (2010). HLA‐DRB1: genetic susceptibility and disability progression in a Spanish multiple sclerosis population. European Journal of Neurology. 18(2). 337–342. 25 indexed citations
11.
Martínez‐Yélamos, Sergio, et al.. (2009). Anticipation of age at onset in familial multiple sclerosis. European Journal of Neurology. 17(4). 572–575. 22 indexed citations
12.
Comi, Giacomo P., Annalisa Pulizzi, Marco Rovaris, et al.. (2008). Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. The Lancet. 371(9630). 2085–2092. 214 indexed citations
13.
Saiz, Albert, Yolanda Blanco, Juan Berenguer, et al.. (2008). [Clinical outcome 6 years after autologous hematopoietic stem cell transplantation in multiple sclerosis].. PubMed. 23(7). 405–7. 20 indexed citations
14.
González-Santiago, Omar, et al.. (2007). Specificity of frontal dysfunctions in relapsing–remitting multiple sclerosis. Archives of Clinical Neuropsychology. 22(5). 623–629. 17 indexed citations
15.
Bruna, Jordi, Sergio Martínez‐Yélamos, Antonio Martı́nez-Yélamos, Francisco Rubio, & T. Arbizu. (2006). Idiopathic acute transverse myelitis: a clinical study and prognostic markers in 45 cases. Multiple Sclerosis Journal. 12(2). 169–173. 37 indexed citations
16.
Fernández, Óscar, T. Arbizu, Guillermo Izquierdo, et al.. (2003). Clinical benefits of interferon beta-1a in relapsing-remitting MS: a phase IV study. Acta Neurologica Scandinavica. 107(1). 7–11. 18 indexed citations
17.
Arbizu, T., et al.. (2000). Interferon beta-1b treatment in patients with relapsing-remitting multiple sclerosis under a standardized protocol in Spain. Acta Neurologica Scandinavica. 102(4). 209–217. 16 indexed citations
18.
Fernández, Óscar, Alfredo Rodríguez Antigüedad, T. Arbizu, et al.. (1999). El interferón beta natural en el tratamiento de la esclerosis múltiple recurrenteremitente: un ensayo clínico de fase II, multicéntrico, aleatorizado y controlado por RMN. Revista de Neurología. 29(12). 1093–1093. 3 indexed citations
19.
Fernández, Óscar, T. Arbizu, P. de Castro, et al.. (1995). Treatment of relapsing–remitting multiple sclerosis with natural interferon beta: a multicenter, randomized clinical trial. Multiple Sclerosis Journal. 1(1_suppl). S67–S69. 12 indexed citations
20.
Sierra, Àngels, Isidró Ferrer, T. Arbizu, & E. Buendía. (1992). [Multiple sclerosis: IL-2, IFN-tau and PGE2 secretion in mononuclear cell cultures stimulated with PHA and the effect of these cytokines on oligodendroglial cells].. Neurología. 7(9). 247–53. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexandra Degenhardt Breakdown of academic impact, for papers by А. Н. Бойко Breakdown of academic impact, for papers by Alexander Musallam Breakdown of academic impact, for papers by M. Cossburn Breakdown of academic impact, for papers by M. S. Freedman Breakdown of academic impact, for papers by Pietro Iaffaldano Breakdown of academic impact, for papers by Peter Huppke Breakdown of academic impact, for papers by Marc Coustans Breakdown of academic impact, for papers by Anton Vladić Breakdown of academic impact, for papers by J. Deans
Rankless by CCL
2026